AstraZeneca PLC (AZN.ST)

AstraZeneca PLC (AZN.ST) Trading on MT5 at XM

At XM we offer AstraZeneca PLC (AZN.ST) stocks as cash CFDs. Our cash CFDs stocks are undated transactions that aim to replicate the cash price of the underlying stock, and so they are adjusted for any relevant corporate actions.

Open a Demo Account
Open an Account

Risk warning: FX and CFD trading involves a high risk of loss.

About AstraZeneca PLC (AZN.ST) Trading

AstraZeneca plc is an Anglo-Swedish multinational company in the pharmaceutical and biopharmaceutical industry that specialises in the manufacturing of products for the treatment of various diseases. The company was founded in 1999 and has its HQ in Cambridge, England. The company stock AZN.ST is a FTSE 100 component and it is traded on both the New York Stock Exchange and on Nasdaq Stockholm.

Trading Conditions

Margin requirement 10 %
Spreads as low as 3.56
Symbols AstraZeneca
Description AstraZeneca PLC
Min. Price Fluctuation 0.01000
Value of Minimum Price Fluctuation SEK 0.1
Value of 1 lot 10 Shares
Min/Max Trade Size 0.4/84
Swap Value in Margin Currency Long -3.4 %
Swap Value in Margin Currency Short -2.6 %
Limit and Stop Levels** 0.05
Total Volume Limit (per client)*** 836
Weekday 10:10-18:15 (GMT +3)
Monday Open 10:10 (GMT +3)   │   Friday Close 18:15 (GMT +3)
** Min. level for placing pending orders at a current market price.

*** Note that the maximum trading volume for AstraZeneca per client is 836 lots. This limit will be reviewed on a daily basis and updated according to the value of the instrument.

How to Start Trading AstraZeneca PLC (AZN.ST)?

Step 1

Open an XM Real Account

Step 2

Download and login to the MT5 platform

Step 3

Double-click on AstraZeneca PLC (AZN.ST) from the “Market Watch” to open an order for this instrument.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.